Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study.
Aglaia SchizaIrma FredrikssonMalin SundAntonios ValachisPublished in: Breast cancer research and treatment (2023)
The present study did not find any sex disparities in NAC utilization or effectiveness in terms of pCR. This supports the current recommendations of treating men with breast cancer with the same indications for NAC as women.
Keyphrases
- neoadjuvant chemotherapy
- transcription factor
- randomized controlled trial
- locally advanced
- systematic review
- lymph node
- sentinel lymph node
- breast cancer risk
- polycystic ovary syndrome
- clinical practice
- rectal cancer
- healthcare
- middle aged
- early stage
- combination therapy
- genome wide analysis
- metabolic syndrome
- young adults
- health insurance